How sulfadoxine-pyrimethamine (SP) was perceived in some rural communities after phasing out chloroquine (CQ) as a first-line drug for uncomplicated malaria in Tanzania: lessons to learn towards moving from monotherapy to fixed combination therapy

Malaria is a leading cause of death in Sub-Saharan Africa. Tanzania changed its malaria treatment policy from chloroquine (CQ) to Sulphadoxine-Pyrimethamine (SP) as first line drug in August 2001. We wanted to assess the perception and behaviour about SP after phasing out chloroquine which was very...

Descripción completa

Detalles Bibliográficos
Autor principal: Nsimba, Stephen ED
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1379633/
https://www.ncbi.nlm.nih.gov/pubmed/16403225
http://dx.doi.org/10.1186/1746-4269-2-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1379633/
https://www.ncbi.nlm.nih.gov/pubmed/16403225
http://dx.doi.org/10.1186/1746-4269-2-5

Ejemplares similares